PFIZER, INC. Toevoegen aan een lijst
|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 25,74 USD | +0,18% |
|
-2,04% | -10,82% |
| 05/12 | Haleon zegt dat Pfizer vertegenwoordiger terugtreedt uit raad van bestuur | AN |
| 04/12 | Novavax verkoopt Tsjechische productie-eenheid aan Novo Nordisk voor $200 miljoen | RE |
Voorlopige winst- en verliesrekening: Pfizer, Inc.
| Fiscaal tijdperk: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 51.750 | 41.908 | 81.288 | 100.330 | 58.496 | 62.916 | 63.277 | 63.846 |
| Variatie | - | -19,02% | 93,97% | 23,43% | -41,7% | 7,56% | 0,57% | 0,9% |
| EBITDA 1 | 21.097 | 17.801 | 25.426 | 42.336 | 15.590 | 24.760 | 25.003 | 26.203 |
| Variatie | - | -15,62% | 42,83% | 66,51% | -63,18% | 58,82% | 0,98% | 4,8% |
| Bedrijfsresultaat (EBIT) 1 | 19.420 | 13.024 | 20.235 | 37.272 | 9.300 | 20.552 | 20.730 | 21.902 |
| Variatie | - | -32,94% | 55,37% | 84,2% | -75,05% | 120,99% | 0,86% | 5,66% |
| Betaalde rente 1 | -1.574 | -1.449 | -1.291 | -1.238 | -2.209 | -3.011 | -2.789 | -2.683 |
| Resultaat voor belastingen (EBT) 1 | 17.682 | 7.497 | 24.311 | 34.729 | 1.058 | 11.511 | 15.079 | 15.819 |
| Variatie | - | -57,6% | 224,28% | 42,85% | -96,95% | 988,02% | 30,99% | 4,91% |
| Nettowinst (verlies) 1 | 16.273 | 9.616 | 21.979 | 31.372 | 2.119 | 9.310 | 12.481 | 13.392 |
| Variatie | - | -40,91% | 128,57% | 42,74% | -93,25% | 339,38% | 34,06% | 7,3% |
| Datum van publicatie | 28-01-20 | 02-02-21 | 08-02-22 | 31-01-23 | 30-01-24 | - | - | - |
1USD in Miljoen
Geschatte gegevens
Balansprognose: Pfizer, Inc.
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuld 1 | 42.320 | 27.615 | 7.367 | 13.097 | 59.198 | 58.242 | 52.128 | 47.219 |
| Variatie | - | -34,75% | -73,32% | 77,78% | 352% | -1,61% | -10,5% | -9,42% |
| Datum van publicatie | 28-01-20 | 02-02-21 | 08-02-22 | 31-01-23 | 30-01-24 | - | - | - |
1USD in Miljoen
Geschatte gegevens
Verwachte kasstroom: Pfizer, Inc.
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 2.176 | 2.252 | 2.711 | 3.236 | 3.907 | 2.774 | 3.022 | 3.027 |
| Variatie | - | 3,49% | 20,38% | 19,37% | 20,74% | -28,99% | 8,92% | 0,15% |
| Vrije kasstroom (FCF) 1 | 10.412 | 12.151 | 29.869 | 26.031 | 4.793 | 10.154 | 16.871 | 17.315 |
| Variatie | - | 16,7% | 145,82% | -12,85% | -81,59% | 111,86% | 66,15% | 2,63% |
| Datum van publicatie | 28-01-20 | 02-02-21 | 08-02-22 | 31-01-23 | 30-01-24 | - | - | - |
1USD in Miljoen
Geschatte gegevens
Verwachte financiële ratio's: Pfizer, Inc.
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
| EBITDA-marge (%) | 40,77% | 42,48% | 31,28% | 42,2% | 26,65% | 39,35% | 39,51% | 41,04% |
| EBIT-marge (%) | 37,53% | 31,08% | 24,89% | 37,15% | 15,9% | 32,67% | 32,76% | 34,3% |
| EBT-marge (%) | 34,17% | 17,89% | 29,91% | 34,61% | 1,81% | 18,3% | 23,83% | 24,78% |
| Nettomarge (%) | 31,45% | 22,95% | 27,04% | 31,27% | 3,62% | 14,8% | 19,72% | 20,98% |
| FCF-marge (%) | 20,12% | 28,99% | 36,74% | 25,95% | 8,19% | 16,14% | 26,66% | 27,12% |
| Vrije kasstroom/nettoresultaat (%) | 63,98% | 126,36% | 135,9% | 82,98% | 226,19% | 109,07% | 135,17% | 129,3% |
Winstgevendheid | ||||||||
| ROA | 9,96% | 5,98% | 13,09% | 19,92% | 4,96% | 6,19% | 6,37% | 7,06% |
| ROE | 25,72% | 15,22% | 31,3% | 43,51% | 11,37% | 18,52% | 17,88% | 17,87% |
Financiële gezondheid | ||||||||
| Hefboom (schuld/ebitda) | 2,01x | 1,55x | 0,29x | 0,31x | 3,8x | 2,35x | 2,08x | 1,8x |
| Schuld/vrije kasstroom | 4,06x | 2,27x | 0,25x | 0,5x | 12,35x | 5,74x | 3,09x | 2,73x |
Kapitaalintensiteit | ||||||||
| Kapitaaluitgaven/omzet (%) | 4,2% | 5,37% | 3,34% | 3,23% | 6,68% | 4,41% | 4,78% | 4,74% |
| CAPEX / EBITDA (%) | 10,31% | 12,65% | 10,66% | 7,64% | 25,06% | 11,21% | 12,09% | 11,55% |
| CAPEX / FCF (%) | 20,9% | 18,53% | 9,08% | 12,43% | 81,51% | 27,32% | 17,91% | 17,48% |
Bestanddelen per aandeel | ||||||||
| Kasstroom per aandeel 1 | 2,218 | 2,557 | 5,708 | 5,105 | 1,524 | 3,555 | 3,17 | 3,212 |
| Variatie | - | 15,29% | 123,19% | -10,56% | -70,15% | 133,26% | -10,81% | 1,33% |
| Dividend per aandeel 1 | 1,44 | 1,52 | 1,56 | 1,61 | 1,65 | 1,683 | 1,721 | 1,715 |
| Variatie | - | 5,56% | 2,63% | 3,21% | 2,48% | 2,03% | 2,2% | -0,33% |
| Nettoactief per aandeel 1 | 11,41 | 11,36 | 13,73 | 17,06 | 15,77 | 15,63 | 16 | 16,5 |
| Variatie | - | -0,45% | 20,91% | 24,2% | -7,57% | -0,88% | 2,4% | 3,14% |
| WPA 1 | 2,87 | 1,71 | 3,85 | 5,47 | 0,37 | 1,649 | 2,129 | 2,334 |
| Variatie | - | -40,42% | 125,15% | 42,08% | -93,24% | 345,57% | 29,12% | 9,63% |
| Aantal aandelen (in duizend) | 5.534.122 | 5.558.397 | 5.612.867 | 5.613.315 | 5.646.413 | 5.666.990 | 5.666.990 | 5.666.990 |
| Datum van publicatie | 28-01-20 | 02-02-21 | 08-02-22 | 31-01-23 | 30-01-24 | - | - | - |
1USD
Geschatte gegevens
| 2024 * | 2025 * | |
|---|---|---|
| K/w-verhouding | 15,6x | 12,1x |
| PBR-ratio | 1,64x | 1,61x |
| EV/omzet | 3,24x | 3,13x |
| Dividendrendement | 6,55% | 6,69% |
Meer waarderingsratio's
* Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
25
Laatste slotkoers
25,70USD
Gemiddelde koersdoel
32,60USD
Spread / Gemiddelde doel
+26,86%
